---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "v6a8ManKjwTpLs4DlDgl24NQ+UltK4YG/wQO8wdInBTmMDkCU1MbRn7mHHmVrNiVGiHO0LZBmawUaUPaV1BM9OM9dbEvkt2cRCW5T2MbFEH5pYSeQ+6Lwv8TJmHl1FZ3fXd6YYcW+8gVzpjJMgtb/bZhBTBJJ6nRn85SNEmzczyJsPI5L8BpxnL0YV4XpC6DCtqb3JJe7PpZJNf6US2wXn8H8C4W1NukSyoKQvSTAkwbwMrJtstHbhI/1WvEwaTP+AltZsDYp4TzZZF2sEjzdP4Vsmn9HKqIt4FYFfYwuDIhQf43i9iQ8yylnY++fq8b;W3j3B0YRstKnzl8r4DhZtw=="
---

